LinkedIn
icn_podcast Podcasts
View All Upcoming Courses
Specialty
Course Type
Search
Login
Specialty
Aesthetics Cardiology Cataract & Refractive Dermatology General Ophthalmology Glaucoma Optometry Retina Women's Health View All Courses
Course Type
Evaluation Supplement Multimedia Webinar Podcast In-Person Multi-part Collection
Search
Login
Menu

Glaucoma Treatment: Tackling Real-World Cases

By: Inder Paul Singh, MD; Dr. Constance Okeke, MD, MSCE

Begin Course

This course has expired. You can still review the content but course credit is no longer available.

Webinar Credits: 1

Topical pharmacologic therapy is the primary treatment for patients with primary open-angle glaucoma and ocular hypertension. However, in many patients multiple medications and different classes of drugs are often needed before there is adequate IOP control. After nearly a decade without new pharmacologic treatments, two new formulations were approved in late 2017. View this case-based webinar to learn how the latest treatments are helping to manage glaucoma.

Expiration Date: Friday, July 15, 2022
Release Date: July 23, 2019

This Educational Activity was made possible in part by a grant from Bausch + Lomb.

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Explain how novel therapeutics differ in their methods of action from other topical medications.
  • Evaluate the safety and efficacy of latanoprostene bunod for ocular hypertension and POAG.
  • Describe how a healthy eye manages IOP in contrast with an unhealthy eye.

Accreditation and Designation Statement

Accreditation Statement
Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
Evolve Medical Education LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Evolve is an approved COPE Administrator.

This course is COPE approved for 1 hour of CE Credit for Optometrists

COPE Course ID: 63377-GL

COPE Event ID: #117787

Faculty and Disclosures

DISCLOSURE POLICY 
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

  • Inder Paul Singh, MD, and/or spouse; has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant and Speaker’s Bureau: Allergan plc., Alcon, Bausch + Lomb, Ellex, Glaukos, Ivantis, New World Medical, and Shire. Grant/Research Support: Ellex, Glaukos, and Sight Sciences.
  • Constance Okeke, MD, MSCE, and/or spouse; has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie Pharmaceuticals, Alcon, Allergan, Bausch + Lomb, Ellex, Glaukos, Medscape, Novartis, and Sight Sciences. Grant/ Research Support: Glaukos. Speaker’s Bureau: Aerie Pharmaceuticals, Alcon, Bausch + Lomb, Ellex, Glaukos, Medscape, and NeoMedix.

EDITORIAL SUPPORT DISCLOSURES 

  • Erin K. Fletcher, MIT, director of compliance and education; Susan Gallagher-Pecha, director of client services and project management; Cassandra Richards, director of education development, Evolve, have no financial relationships with commercial interests. Jaya Kumar, MD, peer reviewer, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan.

Begin Course